Navigation Links
First comprehensive review of European breast cancer screening programs finds benefits outweigh harm
Date:9/12/2012

A major review of breast cancer screening services in Europe, jointly led by researchers at Queen Mary, University of London, has concluded that the benefits of screening in terms of lives saved outweigh the harms caused by over-diagnosis.

The results, which are published in a special supplement of The Journal of Medical Screening [1] today (Thursday), show that for every 1,000 women screened every two years from the age of 50 to the age of about 68-69, between seven and nine lives would be saved, and four cases would be over-diagnosed.

The European Screening Network (EUROSCREEN) working group [2], with members from nine European countries where outcome of screening programmes have been assessed, reviewed the estimates of benefit in published European studies in terms of breast cancer deaths prevented, and the major harms, in particular, the rates of what are called "over-diagnosed" cancers. These are breast cancers diagnosed as a result of screening, which would never have given rise to any symptoms during a woman's lifetime and would not have been diagnosed had she not been screened.

A second working group European Network for Indicators on Cancer (EUNICE) reviewed the organisation, participation rates and main performance parameters of 26 screening programmes in 18 countries, involving 12 million women, between 2001 and 2007 [3]. The reports from both working groups have contributed to the review published today.

Stephen Duffy, Professor of Cancer Screening at the Wolfson Institute of Preventive Medicine at Barts and The London School of Medicine & Dentistry, part of Queen Mary, University of London (UK), who is one of the coordinators of the EUROSCREEN working group and co-author of the supplement, said: "This is the only comprehensive review of the results of breast screening services in Europe. It reports results from screening millions of women, and confirms that the screening services are delivering the benefits expected from the research studies conducted years ago. In particular, it is good news that lives saved by screening outweigh over-diagnosed cases by a factor of two to one."

The researchers also found that for every 1,000 women screened, 170 women would have at least one recall followed by a non-invasive assessment before absence of cancer could be confirmed (a negative result), and 30 women would have at least one recall followed by invasive procedures, such as a biopsy, before confirming a negative result. Screening results that lead to recalls in these circumstances are called "false positives" and can cause women stress and anxiety until the negative result is confirmed.

Dr Eugenio Paci, Director of the Cancer Prevention and Research Institute in Florence, Italy, who is a second EUROSCREEN coordinator and co-author, said: "By weighing up the pros and cons of breast cancer screening programmes we hope to ensure that women are fully aware of the chief benefits and harms and can make a fully informed choice when they decide whether or not they wish to attend screening. There has been quite a lot of discussion recently over the worth of breast cancer screening and for this reason it is timely that the international group of experts has assessed the impact of population-based screening in Europe and has found that it is contributing to the reduction in deaths from the disease.

"We believe that not only should our conclusions be communicated to women offered breast screening in Europe, but that, in addition, communication methods should be improved in order to raise women's awareness, and to make information more accessible, relevant and comprehensible."


'/>"/>
Contact: Emma Mason
e.mason@qmul.ac.uk
Queen Mary, University of London
Source:Eurekalert

Related medicine news :

1. First pediatric study to look at the role of vitamin D in critical illness
2. Researchers find first evidence for a genetic cause for Barretts esophagus
3. London Olympics anti-doping labs set for first-of-a-kind repurposing
4. First validated method for analyzing flavanols and procyanidins in cocoa products could help scientists and the industry in standardized reporting
5. NIH scientists map first steps in flu antibody development
6. Likely voters say presidents first 100 days in office should include plans for research
7. First evidence from humans on how alcohol may boost risk of cancer
8. First identification of a strong oral carcinogen in smokeless tobacco
9. IHME professor named first health measurement winner of prestigious innovation award
10. FDA Gives Nod to First Drug for Diabetic Eye Disease
11. Mayo Clinic completes first genome-wide analysis of peripheral T-cell lymphomas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... ... January 16, 2017 , ... Vixiar ... Officer of the medical device company, effective immediately. , “This is perfect timing ... has a strong track record in medical device market development and revenue growth, ...
(Date:1/15/2017)... ... January 15, 2017 , ... Going above and ... that strives to better communities around the world by offering the Gensuite team ... the opportunity for team members to become involved in a cause that is ...
(Date:1/15/2017)... ... ... "On Tour is a music themed slideshow production package which allows editors ... CEO of Pixel Film Studios. , On Tour’s new slide presets come with ... their slideshows. Place each slide on top of another slide or piece of media ...
(Date:1/15/2017)... ... January 15, 2017 , ... The Gravity Vault Indoor ... Radnor, Pennsylvania. As construction wraps up on the 14,000+ square foot climbing gym, the ... sixth location, including three in New Jersey and two in New York. With this ...
(Date:1/14/2017)... Glendale, CA (PRWEB) , ... January 13, 2017 ... ... published on Body and Soul, incorporating a magnesium-rich Mediterranean diet may lower the ... Leon Café and Lounge notes that the many health and wellness benefits linked ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... LONDON , Jan. 16, 2017  An aneurysm develops ... a balloon-like dilation. Aneurysms can occur in any ... essential blood vessel that supplies blood to legs. Most aortic ... through the abdomen and are referred as abdominal aortic aneurysms, ... the diameter of the aorta in the abdomen is about ...
(Date:1/16/2017)... Jan. 16, 2017  Verathon ® Inc., a leading manufacturer ... of new GlideScope ® Spectrum TM Single-Use video laryngoscopes. ... TM and Ambient Light Reduction TM technology, which actively ... ... Introducing another bright ...
(Date:1/16/2017)... 2017  According to Kalorama Information, the global ... at $4.9 billion for 2016.  The growing number ... aging population with significant diagnostic needs, along with ... the market for the modality.  The healthcare market ... focuses on the worldwide market, providing market size ...
Breaking Medicine Technology: